News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
The companies’ new effort would bypass traditional middlemen, including pharmacy benefit managers and insurers, to cut the drug’s monthly cost from a list price of around $606 to $346
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.